TITLE

Optimal midazolam dose, factors affecting midazolam dose and proper timing of flumazenil injection during esophagogastroduodenoscopy

AUTHOR(S)
Suh, Jung Yul; Sohn, Chong Il; Sung, In Kyung; Jeon, Woo Kyu; Kim, Byung Ik
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS282
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Optimal midazolam dose, factors affecting midazolam dose and proper timing of flumazenil injection during esophagogastroduodenoscopy," by Jung Yul Suh and colleagues is presented.
ACCESSION #
66954667

 

Related Articles

  • Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From In Vitro Inhibition Data. Templeton, I.; Peng, C.-C.; Thummel, K. E.; Davis, C.; Kunze, K. L.; Isoherranen, N. // Clinical Pharmacology & Therapeutics;Oct2010, Vol. 88 Issue 4, p499 

    Inhibitory drug metabolites may contribute to drug-drug interactions (DDIs). The aim of this study was to determine the importance of inhibitory metabolites of itraconazole (ITZ) in in vivo cytochrome P450 (CYP) 3A4 inhibition. The pharmacokinetics of ITZ and midazolam (MDZ) were determined in...

  • Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs*. Lappin, Graham; Kuhnz, Wilhelm; Jochemsen, Roeline; Kneer, Johannes; Chaudhary, Ajai; Oosterhuis, Berend; Drijfhout, Willem Jan; Rowland, Malcolm; Garner, R. Colin // Clinical Pharmacology & Therapeutics;Sep2006, Vol. 80 Issue 3, p203 

    Objectives: A volunteer trial was performed to compare the pharmacokinetics of 5 drugs—warfarin, ZK253 (Schering), diazepam, midazolam, and erythromycin—when administered at a microdose or pharmacologic dose. Each compound was chosen to represent a situation in which prediction of...

  • Single Enteral Loading Dose of Phenobarbital for Achieving Its Therapeutic Serum Levels in Neonates. Turhan, Ali H.; Atici, Aytug; Okuyaz, Cetin; Uysal, Sercan // Croatian Medical Journal;Jun2010, Vol. 51 Issue 3, p215 

    Aim To investigate whether therapeutic serum drug levels may be achieved with a single enteral loading dose of phenobarbital. Methods The study was performed at the Mersin University Hospital in Turkey between April 2004 and August 2006, and included 29 newborn babies with seizure. After the...

  • Single use of fentanyl in colonoscopy is safe and effective and significantly shortens recovery time. Lazaraki, G.; Kountouras, J.; Metallidis, S.; Dokas, S.; Bakaloudis, T.; Chatzopoulos, D.; Gavalas, E.; Zavos, C. // Surgical Endoscopy;Sep2007, Vol. 21 Issue 9, p1631 

    Colonoscopy remains an uncomfortable examination and many patients prefer to be sedated. The aim of this study was to evaluate the efficacy and safety of intravenous administration of fentanyl in titrated doses compared with intravenous administration of the well-known midazolam in titrated...

  • Propofol infusion for sedation during spinal anesthesia. Nishiyama, Tomoki // Journal of Anesthesia;2007, Vol. 21 Issue 2, p265 

    The dose and time course of propofol infusion required to induce rapid sedation without oversedation during spinal anesthesia were investigated. Forty patients scheduled for spinal and epidural anesthesia were studied. After premedication with intramuscular midazolam 0.04 mg·kg−1, an...

  • Sufentanil and Midazolam Dosing and Pharmacogenetic Factors in Pediatric Analgosedation and Withdrawal Syndrome. HRONOVÁ, K.; POKORNÁ, P.; POSCH, L.; SLANAŘ, O. // Physiological Research;2016 Supplement4, Vol. 65, pS463 

    Our aim was to describe the effect of dosing and genetic factors on sufentanil- and midazolam-induced analgosedation and withdrawal syndrome (WS) in pediatric population. Analgosedation and withdrawal syndrome development were monitored using COMFORT-neo/-B scores and SOS score. Length of...

  • Procedural sedation agents.  // Healthcare Traveler;Mar2005, Vol. 12 Issue 9, p36 

    Presents information on the dosage, effect and contraindications of a number of procedural sedation agents. Diazepam; Midazolam; Demerol; Fentanyl; Morphine.

  • Clinical Assessment of New J.V. Sedation Agents and Techniques. PETERSON, L. J. // Journal of Dental Research;Jun1984, Vol. 63 Issue 6, p838 

    The purpose of this paper has been to describe the information that must be gathered before a new drug can be used effectively and safely for I. V. sedation. A new drug, midazolam, has been used as an illustrative example.

  • Correlation between precise and simple tests in recovery of dynamic balance function after intravenous sedation with midazolam in the elderly. Fujisawa, Toshiaki; Takuma, Shigeru; Koseki, Hiroyo; Kimura, Kunie; Fukushima, Kazuaki // Journal of Anesthesia;2007, Vol. 21 Issue 2, p153 

    Assessing the recovery of dynamic balance after intravenous sedation in the elderly is important for ensuring their safe discharge, especially when they are walking. A reliable, simple dynamic balance test would be useful in daily clinical practice. We observed the recovery of balance after...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics